Yoo K Y, Jeong C W, Park B Y, Kim S J, Jeong S T, Shin M H, Lee J
Department of Anaesthesiology, National University Medical School, 8 Hak-dong, Gwangju 501-190, South Korea.
Br J Anaesth. 2009 Jun;102(6):812-9. doi: 10.1093/bja/aep099. Epub 2009 May 8.
We examined the effects of remifentanil on cardiovascular and bispectral index (BIS) responses to tracheal intubation and neonatal outcomes in pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia.
Forty-two women with severe pre-eclampsia were randomly assigned to receive either remifentanil 1 microg kg(-1) (n=21) or saline (n=21) over 30 s before induction of anaesthesia using thiopentone 4 mg kg(-1) and suxamethonium 1.5 mg kg(-1). Mean arterial pressure (MAP), heart rate (HR) and BIS values as well as plasma catecholamine concentrations were measured. Neonatal effects were assessed using Apgar scores and umbilical cord blood gas analysis.
Induction with thiopentone caused a reduction in MAP and BIS in both remifentanil and control groups. Following the tracheal intubation MAP and HR increased in both groups, the magnitude of which was lower in the remifentanil group. BIS values also increased, of which magnitude did not differ between the groups. Norepinephrine concentrations increased significantly following the intubation in the control, while remained unaltered in the remifentanil group. The neonatal Apgar scores at 1 min were significantly lower in the remifentanil group than in the control. However, Apgar scores at 5 min, and umbilical artery and vein blood gas values were similar between the groups.
These results suggest that a single bolus of 1 microg kg(-1) remifentanil effectively attenuates haemodynamic but not BIS responses to tracheal intubation in pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia. However, its use was associated with maternal hypotension and neonatal respiratory depression requiring resuscitation.
我们研究了瑞芬太尼对全身麻醉下行剖宫产的子痫前期患者气管插管时心血管及脑电双频指数(BIS)反应以及新生儿结局的影响。
42例重度子痫前期妇女在使用4mg/kg硫喷妥钠和1.5mg/kg琥珀胆碱诱导麻醉前30秒,随机分为两组,分别接受1μg/kg瑞芬太尼(n = 21)或生理盐水(n = 21)。测量平均动脉压(MAP)、心率(HR)、BIS值以及血浆儿茶酚胺浓度。通过阿氏评分和脐动脉血气分析评估对新生儿的影响。
硫喷妥钠诱导后,瑞芬太尼组和对照组的MAP和BIS均降低。气管插管后两组的MAP和HR均升高,瑞芬太尼组升高幅度较小。BIS值也升高,两组升高幅度无差异。对照组插管后去甲肾上腺素浓度显著升高,而瑞芬太尼组保持不变。瑞芬太尼组1分钟时的新生儿阿氏评分显著低于对照组。然而,两组5分钟时的阿氏评分以及脐动脉和脐静脉血气值相似。
这些结果表明,在全身麻醉下行剖宫产的子痫前期患者中,单次静脉注射1μg/kg瑞芬太尼可有效减轻气管插管时的血流动力学反应,但不能减轻BIS反应。然而,其使用与产妇低血压和需要复苏的新生儿呼吸抑制有关。